Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of cancer-directed therapy at the end of life among adolescents and young adults.
Mack JW, Cernik C, Xu L, Laurent CA, Fisher L, Cannizzaro N, Munneke J, Cooper RM, Lakin JR, Schwartz CM, Casperson M, Altschuler A, Wiener L, Kushi LH, Chao CR, Uno H. Mack JW, et al. Among authors: kushi lh. J Natl Cancer Inst. 2024 Jul 1;116(7):1080-1086. doi: 10.1093/jnci/djae038. J Natl Cancer Inst. 2024. PMID: 38377408
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer.
Rillamas-Sun E, Kwan ML, Carlos C, Cheng R, Neugebauer R, Rana JS, Nguyen-Huynh M, Shi Z, Laurent CA, Lee VS, Roh JM, Huang Y, Shen H, Hershman DL, Kushi LH, Greenlee H. Rillamas-Sun E, et al. Among authors: kushi lh. Res Sq [Preprint]. 2023 Mar 22:rs.3.rs-2675372. doi: 10.21203/rs.3.rs-2675372/v1. Res Sq. 2023. Update in: Breast Cancer Res Treat. 2023 Aug;201(1):117-126. doi: 10.1007/s10549-023-06997-x PMID: 36993531 Free PMC article. Updated. Preprint.
Risk of adverse birth outcomes after adolescent and young adult cancer.
Anderson C, Baggett CD, Engel SM, Getahun D, Cannizzaro NT, Mitra S, Meernik C, Moy LM, Laurent CA, Zhou X, Xu L, Kwan ML, Wood WA, Luke B, Chao CR, Kushi LH, Nichols HB. Anderson C, et al. Among authors: kushi lh. JNCI Cancer Spectr. 2024 Jan 4;8(1):pkad106. doi: 10.1093/jncics/pkad106. JNCI Cancer Spectr. 2024. PMID: 38127994 Free PMC article.
Emergency Department Use in Adolescent and Young Adult Cancer Early Survivors from 2006 to 2020.
Wernli KJ, Haupt EC, Chawla N, Osuji T, Shen E, Smitherman AB, Casperson M, Kirchhoff AC, Zebrack BJ, Keegan THM, Kushi L, Baggett C, Kaddas HK, Ruddy KJ, Sauder CAM, Wun T, Figueroa Gray M, Chubak J, Nichols H, Hahn EE. Wernli KJ, et al. J Adolesc Young Adult Oncol. 2024 Oct;13(5):738-747. doi: 10.1089/jayao.2023.0174. Epub 2024 Apr 29. J Adolesc Young Adult Oncol. 2024. PMID: 38682323
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019.
Bhimani J, O'Connell K, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Rivera DR, Roh JM, Tabatabai S, Valice E, Bowles EJA, Bandera EV, Kushi LH, Kantor ED. Bhimani J, et al. Among authors: kushi lh. Breast Cancer Res. 2024 Jun 13;26(1):101. doi: 10.1186/s13058-024-01822-9. Breast Cancer Res. 2024. PMID: 38872192 Free PMC article.
Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.
Chervo TC, Elkin EP, Nugent JR, Valice E, Amsden LB, Ergas IJ, Munneke JR, Flores M, Saelee GN, Hsiao CA, Schapiro JM, Quesenberry CP, Corley DA, Habel LA, Kushi LH, Skarbinski J. Chervo TC, et al. Among authors: kushi lh. PLoS One. 2024 Jun 20;19(6):e0303303. doi: 10.1371/journal.pone.0303303. eCollection 2024. PLoS One. 2024. PMID: 38900738 Free PMC article.
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer.
Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski R, Ergas IJ, Foley MJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED. Bhimani J, et al. Among authors: kushi lh. Int J Cancer. 2024 Nov 1;155(9):1577-1592. doi: 10.1002/ijc.35053. Epub 2024 Jul 6. Int J Cancer. 2024. PMID: 38970396
A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer.
Liang E, Beshara M, Sheng H, Huang XW, Roh JM, Laurent CA, Lee C, Delmerico J, Tang L, Lo JC, Hong CC, Ambrosone CB, Kushi LH, Kwan ML, Yao S. Liang E, et al. Among authors: kushi lh. Breast Cancer Res Treat. 2024 Nov;208(2):349-358. doi: 10.1007/s10549-024-07423-6. Epub 2024 Jul 8. Breast Cancer Res Treat. 2024. PMID: 38976164
394 results